Recombinant adeno associated virus (rAAV) encoding GJB2 and uses thereof

The present disclosure, at least in part, relates to compositions (e.g., isolated nucleic acid and rAAVs) and methods for treating Non-syndromic hearing loss and deafness (DFNB1) by delivering gap junction beta 2 (GJB2) protein to inner ear cells that normally express GJB2 (e.g., fibrocytes and supp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BOOTH, KEVIN T, IVANCHENKO, MARYNA V, HRVATIN, SINISA, GREENBERG, MICHAEL E, PETERS, COLE W. D, NAGY, MARK AUREL, COREY, DAVID P, GRIFFITH, ERIC C
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BOOTH, KEVIN T
IVANCHENKO, MARYNA V
HRVATIN, SINISA
GREENBERG, MICHAEL E
PETERS, COLE W. D
NAGY, MARK AUREL
COREY, DAVID P
GRIFFITH, ERIC C
description The present disclosure, at least in part, relates to compositions (e.g., isolated nucleic acid and rAAVs) and methods for treating Non-syndromic hearing loss and deafness (DFNB1) by delivering gap junction beta 2 (GJB2) protein to inner ear cells that normally express GJB2 (e.g., fibrocytes and supporting cells of the organ of Corti and nearby regions). The isolated nucleic acid of the present disclosure comprises an expression cassette, wherein the expression cassette comprises a gap junction beta 2 (GJB2) gene regulatory element (GRE) (e.g., GJB2 enhancers, GJB2 promoters, GJB2 5' UTR, and/or GJB2 3' UTR), and a nucleotide sequence encoding a GJB2 protein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202227476A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202227476A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202227476A3</originalsourceid><addsrcrecordid>eNqNyrEKwjAQBuAuDqK-w7npIEgUO0dRi6MUHcs1-asBvZRc6vO7-ABO3_KNi-oKF99tEJZM7CGRWDW6wBmePiENSotk7W1JEBd9kAedL3tDLJ4GhVJ-IiF202LU8Usx-zkp5qdjfahW6GMD7dlBkJv6btbGmHJb7uzmn_MFEcYzHA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Recombinant adeno associated virus (rAAV) encoding GJB2 and uses thereof</title><source>esp@cenet</source><creator>BOOTH, KEVIN T ; IVANCHENKO, MARYNA V ; HRVATIN, SINISA ; GREENBERG, MICHAEL E ; PETERS, COLE W. D ; NAGY, MARK AUREL ; COREY, DAVID P ; GRIFFITH, ERIC C</creator><creatorcontrib>BOOTH, KEVIN T ; IVANCHENKO, MARYNA V ; HRVATIN, SINISA ; GREENBERG, MICHAEL E ; PETERS, COLE W. D ; NAGY, MARK AUREL ; COREY, DAVID P ; GRIFFITH, ERIC C</creatorcontrib><description>The present disclosure, at least in part, relates to compositions (e.g., isolated nucleic acid and rAAVs) and methods for treating Non-syndromic hearing loss and deafness (DFNB1) by delivering gap junction beta 2 (GJB2) protein to inner ear cells that normally express GJB2 (e.g., fibrocytes and supporting cells of the organ of Corti and nearby regions). The isolated nucleic acid of the present disclosure comprises an expression cassette, wherein the expression cassette comprises a gap junction beta 2 (GJB2) gene regulatory element (GRE) (e.g., GJB2 enhancers, GJB2 promoters, GJB2 5' UTR, and/or GJB2 3' UTR), and a nucleotide sequence encoding a GJB2 protein.</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220716&amp;DB=EPODOC&amp;CC=TW&amp;NR=202227476A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25566,76549</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220716&amp;DB=EPODOC&amp;CC=TW&amp;NR=202227476A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BOOTH, KEVIN T</creatorcontrib><creatorcontrib>IVANCHENKO, MARYNA V</creatorcontrib><creatorcontrib>HRVATIN, SINISA</creatorcontrib><creatorcontrib>GREENBERG, MICHAEL E</creatorcontrib><creatorcontrib>PETERS, COLE W. D</creatorcontrib><creatorcontrib>NAGY, MARK AUREL</creatorcontrib><creatorcontrib>COREY, DAVID P</creatorcontrib><creatorcontrib>GRIFFITH, ERIC C</creatorcontrib><title>Recombinant adeno associated virus (rAAV) encoding GJB2 and uses thereof</title><description>The present disclosure, at least in part, relates to compositions (e.g., isolated nucleic acid and rAAVs) and methods for treating Non-syndromic hearing loss and deafness (DFNB1) by delivering gap junction beta 2 (GJB2) protein to inner ear cells that normally express GJB2 (e.g., fibrocytes and supporting cells of the organ of Corti and nearby regions). The isolated nucleic acid of the present disclosure comprises an expression cassette, wherein the expression cassette comprises a gap junction beta 2 (GJB2) gene regulatory element (GRE) (e.g., GJB2 enhancers, GJB2 promoters, GJB2 5' UTR, and/or GJB2 3' UTR), and a nucleotide sequence encoding a GJB2 protein.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQBuAuDqK-w7npIEgUO0dRi6MUHcs1-asBvZRc6vO7-ABO3_KNi-oKF99tEJZM7CGRWDW6wBmePiENSotk7W1JEBd9kAedL3tDLJ4GhVJ-IiF202LU8Usx-zkp5qdjfahW6GMD7dlBkJv6btbGmHJb7uzmn_MFEcYzHA</recordid><startdate>20220716</startdate><enddate>20220716</enddate><creator>BOOTH, KEVIN T</creator><creator>IVANCHENKO, MARYNA V</creator><creator>HRVATIN, SINISA</creator><creator>GREENBERG, MICHAEL E</creator><creator>PETERS, COLE W. D</creator><creator>NAGY, MARK AUREL</creator><creator>COREY, DAVID P</creator><creator>GRIFFITH, ERIC C</creator><scope>EVB</scope></search><sort><creationdate>20220716</creationdate><title>Recombinant adeno associated virus (rAAV) encoding GJB2 and uses thereof</title><author>BOOTH, KEVIN T ; IVANCHENKO, MARYNA V ; HRVATIN, SINISA ; GREENBERG, MICHAEL E ; PETERS, COLE W. D ; NAGY, MARK AUREL ; COREY, DAVID P ; GRIFFITH, ERIC C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202227476A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>BOOTH, KEVIN T</creatorcontrib><creatorcontrib>IVANCHENKO, MARYNA V</creatorcontrib><creatorcontrib>HRVATIN, SINISA</creatorcontrib><creatorcontrib>GREENBERG, MICHAEL E</creatorcontrib><creatorcontrib>PETERS, COLE W. D</creatorcontrib><creatorcontrib>NAGY, MARK AUREL</creatorcontrib><creatorcontrib>COREY, DAVID P</creatorcontrib><creatorcontrib>GRIFFITH, ERIC C</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BOOTH, KEVIN T</au><au>IVANCHENKO, MARYNA V</au><au>HRVATIN, SINISA</au><au>GREENBERG, MICHAEL E</au><au>PETERS, COLE W. D</au><au>NAGY, MARK AUREL</au><au>COREY, DAVID P</au><au>GRIFFITH, ERIC C</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Recombinant adeno associated virus (rAAV) encoding GJB2 and uses thereof</title><date>2022-07-16</date><risdate>2022</risdate><abstract>The present disclosure, at least in part, relates to compositions (e.g., isolated nucleic acid and rAAVs) and methods for treating Non-syndromic hearing loss and deafness (DFNB1) by delivering gap junction beta 2 (GJB2) protein to inner ear cells that normally express GJB2 (e.g., fibrocytes and supporting cells of the organ of Corti and nearby regions). The isolated nucleic acid of the present disclosure comprises an expression cassette, wherein the expression cassette comprises a gap junction beta 2 (GJB2) gene regulatory element (GRE) (e.g., GJB2 enhancers, GJB2 promoters, GJB2 5' UTR, and/or GJB2 3' UTR), and a nucleotide sequence encoding a GJB2 protein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_TW202227476A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title Recombinant adeno associated virus (rAAV) encoding GJB2 and uses thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T06%3A37%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BOOTH,%20KEVIN%20T&rft.date=2022-07-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202227476A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true